Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are older than 20 years of age
- You have been diagnosed with advanced or metastatic renal cell carcinoma (a type of kidney cancer that has spread or is at an advanced stage)
- You are about to start a type of cancer treatment that works through the immune system (called immunotherapy or IO-based therapy)
- Your general health and ability to carry out daily activities falls within an accepted range, from fully active to limited self-care (confirm with trial site)
- Your doctors expect you to live for more than 3 months
- Your kidneys are still functioning at a minimum acceptable level, specifically at Stage 4 chronic kidney disease or better (confirm with trial site)
- You are willing to read and sign a consent form agreeing to take part in the study
Who may not be able to join:
- You are not willing to sign the consent form for the study
- You currently have an active infection or an active urinary tract infection (a urine test would check for this)
- You have another type of cancer that currently requires active treatment (if you have another cancer that does not need treatment right now, you may still be eligible)
- You are currently taking medicines that affect your immune system, such as steroids or immune-suppressing drugs (the trial team will decide if this applies to you)
- You have previously received any immunotherapy (IO-based therapy) for your cancer
- You have received most types of systemic (whole-body) cancer treatments within the last 4 weeks — however, if it has been more than 4 weeks since your last treatment, or if you are on or have had targeted therapy specifically, you may still be eligible (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 886-2-23123456
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate (ORR); Progression-free survival (PFS); Duration of response (DOR); Overall survival (OS); Adverse event of special interest (AESI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.